Medtech Insight and Windhover Information's 'Investment In Innovation' Medical Technology Investment Conference to Feature Interactive Panel Discussing the Relationship Between VCs and Entrepreneurs.
Medtech Insight, a division of Windhover Information and a leading provider of business information on new trends, technologies and emerging companies in the medical device industry, has announced that its upcoming "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference, to be held Oct. 21-22, 2004, at The Westin Copley Place Hotel in Boston, will feature a dynamic, interactive panel discussion titled "Seeing Eye to Eye: The Relationship between VCs and Entrepreneurs."
The session will be moderated by David Cassak, managing partner at Windhover Information, a healthcare market expert with over 20 years of industry experience. Panelists participating in the Friday afternoon, Oct. 22 discussion will include a number of leading venture capitalists and serial entrepreneurs, such as Rob Andrews, director of Healthcare Investment Banking at Houlihan Lokey Howard & Zukin, and Kenneth L. Cutler, partner and co-chair, Emerging Companies, at Dorsey & Whitney LLP, among others to be announced.
The In3 Boston conference will also feature presentations from approximately 60 emerging medical technology companies seeking funding, acquisition, and/or strategic partnership opportunities. Presenting companies will represent a diverse range of major medical device sectors including cardiovascular and neurovascular disease, spine/orthopedics, imaging and surgical navigation technology, critical care, oncology, drug delivery, women's health and oncology, among others. Companies confirmed thus far to present at the Boston event include: Access Bio, Access CardioSystems, Acologix, Acta Vascular Systems, Adiana, Advanced Bioelectric, Advanced Medical Diagnostics, Affinergy, Applied Spine Technologies, Argentum Medical, Audiomedix, BioCare Systems, BioniCare Medical Technologies, Biowave, Bone Solutions, Cardiac Assist, Cardio-Optics, Cerdak, Chiroxia, Clinicon, Cordeus, CoreValve, Endomed, GARRETTtechnologies, Gene Express, GlucoLight, Haptica, Hayes Medical, Heart Assist Technologies, HemaMetrics, Intelligent Medical Devices, Keimar, LifeAssays, LumeRx, Mazor Surgical Technologies, MDMI Technologies, MicroMRI, MINRAD, MiTiHeart, Monteris Medical, Nanolution, Nervonix, NMT Medical, NovoSci, NsGene, OMRIX biopharmaceuticals, Os Technology, OsteoResorb, Percardia, Polymerix, Proxy Biomedical, SafetyNet, SmokeSignals, Stheno, Triton BioSystems, Utopix, Valor Medical, Viking Systems, and ZARS (see www.medtechinsight.com for an updated listing and descriptions of each company's technology).
The conference will be attended by approximately 400 senior executives from most of the leading healthcare investment firms and medical device companies. See the Medtech Insight Web site at http://www.medtechinsight.com/in3-12.html for conference details and registration information.
The Boston conference will be kicked off by a keynote presentation by industry veteran Rick Randall, whose medical device industry experience includes positions as president and CEO of Target Therapeutics, Incumed, Innovasive Devices, and Conceptus. Randall is currently president and CEO of TranS1, a development-stage, minimally invasive spine surgery company. Featured speakers include Kevin Collins, partner, and Janet MacLeod, Ph.D., associate, at Dorsey & Whitney LLP, speaking to meeting participants about "Setting Up Your Company for Successful Acquisition," and James M. Garvey, managing partner and CEO of Schroder Ventures Life Sciences, who will discuss "The State of Healthcare Investing in 2004 and Beyond." In addition, Harvey Rudolph, Ph.D., Global Medical Program manager at Underwriters Laboratories, will add his insights in a presentation titled "Why Do I Have To Do Risk Management?"
Rounding out the Boston program will be an informative panel discussion organized by the investment banking firm Houlihan Lokey Howard & Zukin titled "Valuation Methodologies for Early- and Late-Stage Medical Technology Companies." Panelists for this discussion include Rob Andrews, director of Healthcare Investment Banking, Gary Brewster, senior vice president, and Naomi Derner, vice president, at Houlihan Lokey Howard & Zukin.
In3 Boston is a must-attend event for anyone interested in emerging medical technology companies. To register, call Medtech Insight at 949-219-0150, or 888-290-2225 toll-free in the United States, or register on the Medtech Insight Web site at http://www.medtechinsight.com/in3-12.html. To read what industry experts think of Medtech Insight's conferences, please visit http://www.medtechinsight.com/in3success.html.
ABOUT MEDTECH INSIGHT
Recently acquired by Windhover Information Inc., publisher of IN VIVO: The Business & Medicine Report, and Start-UP: Windhover's Review of Emerging Technologies, Medtech Insight is a leading provider of business information for the medical technology marketplace. The company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry. The company also publishes analyses of medtech markets through its Market & Technology Reports group, offers custom consulting and market research, and holds medical technology investment conferences several times a year.
To register for the Boston conference or for more information on the company's upcoming "IN SPINE: Strategic Partnering and Investing in Spine" conference, being held in Dallas on Nov. 11, 2004, please call 949-219-0150 or 888-290-2225 toll-free in the United States, fax 949-219-0067, e-mail email@example.com, or visit www.medtechinsight.com. Visit the company's Web site to read more about the company's upcoming conferences, view tables of contents for published and upcoming reports, and download a sample issue of the "medtech insight" newsletter. Windhover Information Inc. (http://www.windhover.com/), based in Norwalk, Conn., is a leading provider of information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries.
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 21, 2004|
|Previous Article:||With Aggressive Release Schedule Through Remainder of 2004, BuilderMT Will Introduce `Click to Learn Help System,' One-Click `Auto-Updates,' and...|
|Next Article:||JLM Couture, Inc. Reports Third Quarter Results.|